RUSSELL J STRUBLE
Allopathic & Osteopathic Physicians|Family Medicine BAY CITY, MI NPI 1154355477
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine MI Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$2,121.76
- Category: General Payments
- Program years: PY2018–2021
- Record count: 202
- As of (CMS publication): 2026-01-23
Latest program year (PY2021): $112.75 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2021) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $112.75 | 8 |
By paying entity
Latest program year (PY2021) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $35.06 | 2 |
| Lilly USA, LLC | $23.96 | 2 |
| Teva Pharmaceuticals USA, Inc. | $15.10 | 1 |
| Janssen Pharmaceuticals, Inc | $14.68 | 1 |
| Acerta Pharma LLC | $12.15 | 1 |
| GlaxoSmithKline, LLC. | $11.80 | 1 |
By program year
Records — PY2021 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 763550600 | Boehringer Ingelheim Pharmaceuticals, Inc. | $14.31 | 07/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 763550602 | Boehringer Ingelheim Pharmaceuticals, Inc. | $20.75 | 07/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 787930691 | Janssen Pharmaceuticals, Inc | $14.68 | 05/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 802281155 | GlaxoSmithKline, LLC. | $11.80 | 06/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 818696281 | Lilly USA, LLC | $12.67 | 07/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 818747567 | Lilly USA, LLC | $11.29 | 05/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 829356087 | AstraZeneca Pharmaceuticals LP | $12.15 | 06/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 839633145 | Teva Pharmaceuticals USA, Inc. | $15.10 | 07/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.